Background and Purpose-Patients with large middle cerebral artery infarctio
n and elevated intracranial pressure (ICP) who are undergoing invasive inte
nsive care therapy require technical monitoring. However, the effectiveness
of the current gold standard, measurement of lCP, is limited. Furthermore,
the effects of what is considered to be standard antiedema medical treatme
nt are not fully understood. We studied whether multimodal monitoring can h
elp to overcome this problem.
Methods-ICP, cerebral perfusion pressure (CPP), and partial brain tissue ox
ygen pressure (Pbro(2)) were continuously measured within the white matter
of the frontal lobe unilaterally or bilaterally. We analyzed the effects of
antiedema drugs and looked for pattern changes in the Pbro2 before transte
ntorial herniation in patients in whom this could not be prevented. Further
more, complications were registered.
Results-We performed 27 measurements in 21 patients. A total of 297 antiede
ma drug administrations were analyzed in 11 patients. Hyper-HAES and mannit
ol were most often associated with an increase in CPP and Pbro(2), whereas
the use of thiopental and tromethamine led to negative or contrary effects,
although ICP was decreased in every case. Pattern changes in the Pbro(2) c
urve could be observed between 6 to 18 hours before transtentorial herniati
on. No bleeding complication or infections were observed.
Conclusions-Multimodal monitoring can be used to monitor antiedema drug eff
ects. Our data suggest that with multimodal monitoring, pathophysiological
changes could be predicted considerably in advance. ICP alone is of questio
nable use. Furthermore, this method might help to optimize the timing of in
vasive therapy in space-occupying infarction.